TNF-mediated cytotoxicity and resistance in human prostate cancer cell lines
β Scribed by Nakajima, Yosuke; DelliPizzi, Ann Marie; Mallouh, Camille; Ferreri, Nicholas R.
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 646 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND.
The contribution of TNF receptor (TNF-R) expression was investigated with respect to TNF sensitivity or insensitivity for androgen-dependent and androgenindependent human prostate cancer (PCA) cell lines, respectively.
METHODS.
Flow cytometric analyses using monoclonal antibodies against the 55-kDa receptor (TNF-Rl) and the 75-kDa receptor (TNF-R2) indicated that both receptors were expressed on all three cell lines.
RESULTS.
Moreover, expression of TNF-R1 was greater than expression of TNF-R2 in these PCA cells, AU three PCA cell lines produced IL-6. However, IL-6 production was enhanced when TNF-insensitive JCA-1 and PC-3 cells, but not TNF-sensitive LNCaP cells, were treated with rTNF M).
CONCLUSIONS. These data suggest that the lack of an antiproliferative effect of rTNF on the androgen-independent PCA cell lines PC-3 and JCA-1 is not due to the failure of these cells to express TNF-R, but may be related to the differences in TNF-mediated IL-6 expression by these PCA cell lines.
π SIMILAR VOLUMES
## Abstract Lymphocytes from patients with bladder, renal or prostate carcinomas, or with nonβmalignant genitoβurinary disorders, and from normal individuals, were tested in a microcytotoxicity test against cultured bladder cancer cells (T24) and other target cell types. Effector cells were titrate
## BACKGROUND. Apoptosis, or programmed cell death, can be mediated through an endogenous signaling pathway that emanates from a cell surface receptor known as Fas. Although best recognized for its role in the immune system, recent studies have also suggested a role for Fas in mediating apoptosis
Progression to androgen independence remains the main problem that impacts on survival and quality of life in prostate cancer patients. We have investigated the potency of tributyrin, an orally available prodrug of butyrate, to induce growth arrest, differentiation and apoptosis in LNCaP, PC-3 and T